INT131 Besylate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INT131 Besylate, covering 2010-09-13 to 2010-09-13. Get the full timeline:
Most recent: Clinical Trial Update: A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator [Phase 2]